6UV-73108-67543

4 vaccinations 12 coded responses 46 check-ins 11 free-text entries 4 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 532 / WI
Registered: 2021-03-04

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2528850 (opens in a new window)	high	11 / 11	—	8 of 12 VAERS symptoms	same dose (4)	WI matches	2022-09-09 / 2022-11-28 / 2022-12-12 received 91 days before the last call	case 319911

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Registered in v-safe
2021-03-04
Dose 1 — Moderna
2021-03-04
Health check-in — day 0, dose 1
Feeling: Good · Fever · Headache

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-11
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-03-18
Survey response — day 14, dose 1
MedDRA: Asthenia, Fatigue, Headache, Migraine — Feeling: Good · Be unable to work

Free text: Fatigue, low energy, headache/migraine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-01
Dose 2 — Moderna
2021-04-01
Survey response — day 0, dose 2
MedDRA: No adverse event — Feeling: Good

Free text: None as of about 90 minutes after injection.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fever · Muscle or body aches

Adult check-in
2021-04-03
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site pain, Myalgia — Feeling: Good · Muscle or body aches

Free text: Muscle ache seems to be from overuse of arm muscles when moving the arm after injection to aviod injection site pain.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fever · None

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work

Adult check-in
2021-04-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fever · Headache

Adult check-in
2021-04-08
Health check-in — day 7, dose 2
Feeling: Good · Fever · Headache

Adult check-in
2021-04-15
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-04-22
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-29
Survey response — day 28, dose 2
MedDRA: Fatigue, Headache, Migraine — Feeling: Fair · Be unable to do your normal daily activities

Free text: Continuing migraine and pro-migraine, headache, fatigue.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Survey response — day 35, dose 2
MedDRA: Anosmia, Disturbance in attention, Fatigue, Headache, Sensitisation — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Fatigue, difficulty focusing on tasks, headache, sensitivity to scents and sound

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-13
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-01
Survey response — 3 months, dose 2
MedDRA: Dysmenorrhoea, Headache, Intermenstrual bleeding — Feeling: Fair · Be unable to do your normal daily activities

Free text: Headache, menstrual cramps (despite hormonal birth control), menstrual spotting (despite hormonal birth control and no periods for years).

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-12-17
Dose 3 — Moderna
2021-12-17
Health check-in — day 0, dose 3
Feeling: Good · Headache

Adult check-in
2021-12-18
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-19
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-12-20
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-21
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-12-22
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-12-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Chills, Headache

Adult check-in
2021-12-24
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-31
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-07
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-16
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-21
Survey response — day 35, dose 3
MedDRA: Headache, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Increased frequency and severity of headache, migraine

MedDRA releases: 2024-11 · check-in free text available
2022-01-21
Report sent to call center — day 35, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-25
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-30
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-03-18
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-06-17
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-09
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-09-29
Survey response — day 14, dose 4
MedDRA: Allergic respiratory symptom, Cough, Migraine, Oropharyngeal pain, Rhinorrhoea, Sinus disorder, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Allery-like sinus symptoms, including sore throat, running nose, sneezing, cough. Also increased migraine frequency.

MedDRA releases: 2024-11 · check-in free text available
2022-09-29
Report sent to call center — day 14, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-30
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-07
Survey response — day 28, dose 4
MedDRA: Impaired work ability, Loss of personal independence in daily activities, Migraine, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Increased incidence of migraine, missing two days of work/school in one week (usual occurrence is approximately once per month).

MedDRA releases: 2024-11 · check-in free text available
2022-10-14
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-10-21
Survey response — day 42, dose 4
MedDRA: Arthralgia, Migraine, Muscle tightness, Neck pain, Tension headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Significant tense muscles and soreness in neck and shoulders, leading to tension headaches and migraine.

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Survey response — 3 months, dose 4
MedDRA: Cough, Headache, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Tested positive for COVID, mild symptoms, had symptom relapse after initial improvement and medication (Paxlovid, Prednisone). Included headache, head congestion, cough, slight fever on day 1 that did not relapse. Today is day 10, still symptomatic

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-12
Call successful
Completed over the phone
2022-12-12
Call successful
Completed over the phone
2023-03-10
Survey response — 6 months, dose 4
MedDRA: Brain fog, Condition aggravated, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-03-10
Report sent to call center — 6 months, dose 4
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-03-13
Call successful
Reported to VAERS during previous contact from GDIT

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Moderna
2	2021-04-01	Moderna
3	2021-12-17	Moderna	No
4	2022-09-09	Pfizer-BioNTech	Flu

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 5 — day 14, dose 1

2021-03-18

Symptoms: Fatigue, low energy, headache/migraine.

Release 6 — day 0, dose 2

2021-04-01

Systemic reaction (other): None as of about 90 minutes after injection.

Release 6 — days 1–6 daily, dose 2

2021-04-03

Systemic reaction (other): Muscle ache seems to be from overuse of arm muscles when moving the arm after injection to aviod injection site pain.

Release 8 — day 28, dose 2

2021-04-29

Symptoms: Continuing migraine and pro-migraine, headache, fatigue.

Release 8 — day 35, dose 2

2021-05-06

Symptoms: Fatigue, difficulty focusing on tasks, headache, sensitivity to scents and sound

Release 9 — 3 months, dose 2

2021-07-01

Symptoms: Headache, menstrual cramps (despite hormonal birth control), menstrual spotting (despite hormonal birth control and no periods for years).

Release 11 — day 35, dose 3

2022-01-21

Symptoms: Increased frequency and severity of headache, migraine

Release 12 — day 14, dose 4

2022-09-29

Symptoms: Allery-like sinus symptoms, including sore throat, running nose, sneezing, cough. Also increased migraine frequency.

Release 12 — day 28, dose 4

2022-10-07

Symptoms: Increased incidence of migraine, missing two days of work/school in one week (usual occurrence is approximately once per month).

Release 12 — day 42, dose 4

2022-10-21

Symptoms: Significant tense muscles and soreness in neck and shoulders, leading to tension headaches and migraine.

Release 12 — 3 months, dose 4

2022-12-09

Symptoms: Tested positive for COVID, mild symptoms, had symptom relapse after initial improvement and medication (Paxlovid, Prednisone). Included headache, head congestion, cough, slight fever on day 1 that did not relapse. Today is day 10, still symptomatic cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Allergic respiratory symptom	·	·	✓
SD	Anosmia	✓	✓	✓
SD	Arthralgia	·	·	✓
SD	Asthenia	✓	✓	✓
SD	Brain fog	·	·	✓
SD	Condition aggravated	·	·	✓
SD	Cough	·	·	✓
SD	Disturbance in attention	✓	✓	✓
SD	Dysmenorrhoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Impaired work ability	·	·	✓
SD	Intermenstrual bleeding	✓	✓	✓
SD	Loss of personal independence in daily activities	·	·	✓
SD	Migraine	✓	✓	✓
SD	Muscle tightness	·	·	✓
SD	Neck pain	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓
SD	Sensitisation	✓	✓	✓
SD	Sinus disorder	·	·	✓
SD	Sneezing	·	·	✓
SD	Tension headache	·	·	✓
SRO	Injection site pain	✓	✓	✓
SRO	Myalgia	✓	✓	✓
SRO	No adverse event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release